Cargando…
Medermycin Inhibits TNFα-Promoted Inflammatory Reaction in Human Synovial Fibroblasts
Synovial inflammation plays a crucial role in the destruction of joints and the experience of pain in osteoarthritis (OA). Emerging evidence suggests that certain antibiotic agents and their derivatives possess anti-inflammatory properties. Medermycin (MED) has been identified as a potent antibiotic...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531480/ https://www.ncbi.nlm.nih.gov/pubmed/37762174 http://dx.doi.org/10.3390/ijms241813871 |
_version_ | 1785111728775757824 |
---|---|
author | Inoue, Sho Inahashi, Yuki Itakura, Makoto Inoue, Gen Muneshige, Kyoko Hirose, Tomoyasu Iwatsuki, Masato Takaso, Masashi Miyagi, Masayuki Uchida, Kentaro |
author_facet | Inoue, Sho Inahashi, Yuki Itakura, Makoto Inoue, Gen Muneshige, Kyoko Hirose, Tomoyasu Iwatsuki, Masato Takaso, Masashi Miyagi, Masayuki Uchida, Kentaro |
author_sort | Inoue, Sho |
collection | PubMed |
description | Synovial inflammation plays a crucial role in the destruction of joints and the experience of pain in osteoarthritis (OA). Emerging evidence suggests that certain antibiotic agents and their derivatives possess anti-inflammatory properties. Medermycin (MED) has been identified as a potent antibiotic, specifically active against Gram-positive bacteria. In this study, we aimed to investigate the impact of MED on TNFα-induced inflammatory reactions in a synovial cell line, SW-982, as well as primary human synovial fibroblasts (HSF) using RNA sequencing, rtRT-PCR, ELISA, and western blotting. Through the analysis of differentially expressed genes (DEGs), we identified a total of 1478 significantly upregulated genes in SW-982 cells stimulated with TNFα compared to the vehicle control. Among these upregulated genes, MED treatment led to a reduction in 1167 genes, including those encoding proinflammatory cytokines such as IL1B, IL6, and IL8. Pathway analysis revealed the enrichment of DEGs in the TNF and NFκB signaling pathway, further supporting the involvement of MED in modulating inflammatory responses. Subsequent experiments demonstrated that MED inhibited the expression of IL6 and IL8 at both the mRNA and protein levels in both SW982 cells and HSF. Additionally, MED treatment resulted in a reduction in p65 phosphorylation in both cell types, indicating its inhibitory effect on NFκB activation. Interestingly, MED also inhibited Akt phosphorylation in SW982 cells, but not in HSF. Overall, our findings suggest that MED suppresses TNFα-mediated inflammatory cytokine production and p65 phosphorylation. These results highlight the potential therapeutic value of MED in managing inflammatory conditions in OA. Further investigations utilizing articular chondrocytes and animal models of OA may provide valuable insights into the therapeutic potential of MED for this disease. |
format | Online Article Text |
id | pubmed-10531480 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-105314802023-09-28 Medermycin Inhibits TNFα-Promoted Inflammatory Reaction in Human Synovial Fibroblasts Inoue, Sho Inahashi, Yuki Itakura, Makoto Inoue, Gen Muneshige, Kyoko Hirose, Tomoyasu Iwatsuki, Masato Takaso, Masashi Miyagi, Masayuki Uchida, Kentaro Int J Mol Sci Article Synovial inflammation plays a crucial role in the destruction of joints and the experience of pain in osteoarthritis (OA). Emerging evidence suggests that certain antibiotic agents and their derivatives possess anti-inflammatory properties. Medermycin (MED) has been identified as a potent antibiotic, specifically active against Gram-positive bacteria. In this study, we aimed to investigate the impact of MED on TNFα-induced inflammatory reactions in a synovial cell line, SW-982, as well as primary human synovial fibroblasts (HSF) using RNA sequencing, rtRT-PCR, ELISA, and western blotting. Through the analysis of differentially expressed genes (DEGs), we identified a total of 1478 significantly upregulated genes in SW-982 cells stimulated with TNFα compared to the vehicle control. Among these upregulated genes, MED treatment led to a reduction in 1167 genes, including those encoding proinflammatory cytokines such as IL1B, IL6, and IL8. Pathway analysis revealed the enrichment of DEGs in the TNF and NFκB signaling pathway, further supporting the involvement of MED in modulating inflammatory responses. Subsequent experiments demonstrated that MED inhibited the expression of IL6 and IL8 at both the mRNA and protein levels in both SW982 cells and HSF. Additionally, MED treatment resulted in a reduction in p65 phosphorylation in both cell types, indicating its inhibitory effect on NFκB activation. Interestingly, MED also inhibited Akt phosphorylation in SW982 cells, but not in HSF. Overall, our findings suggest that MED suppresses TNFα-mediated inflammatory cytokine production and p65 phosphorylation. These results highlight the potential therapeutic value of MED in managing inflammatory conditions in OA. Further investigations utilizing articular chondrocytes and animal models of OA may provide valuable insights into the therapeutic potential of MED for this disease. MDPI 2023-09-08 /pmc/articles/PMC10531480/ /pubmed/37762174 http://dx.doi.org/10.3390/ijms241813871 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Inoue, Sho Inahashi, Yuki Itakura, Makoto Inoue, Gen Muneshige, Kyoko Hirose, Tomoyasu Iwatsuki, Masato Takaso, Masashi Miyagi, Masayuki Uchida, Kentaro Medermycin Inhibits TNFα-Promoted Inflammatory Reaction in Human Synovial Fibroblasts |
title | Medermycin Inhibits TNFα-Promoted Inflammatory Reaction in Human Synovial Fibroblasts |
title_full | Medermycin Inhibits TNFα-Promoted Inflammatory Reaction in Human Synovial Fibroblasts |
title_fullStr | Medermycin Inhibits TNFα-Promoted Inflammatory Reaction in Human Synovial Fibroblasts |
title_full_unstemmed | Medermycin Inhibits TNFα-Promoted Inflammatory Reaction in Human Synovial Fibroblasts |
title_short | Medermycin Inhibits TNFα-Promoted Inflammatory Reaction in Human Synovial Fibroblasts |
title_sort | medermycin inhibits tnfα-promoted inflammatory reaction in human synovial fibroblasts |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531480/ https://www.ncbi.nlm.nih.gov/pubmed/37762174 http://dx.doi.org/10.3390/ijms241813871 |
work_keys_str_mv | AT inouesho medermycininhibitstnfapromotedinflammatoryreactioninhumansynovialfibroblasts AT inahashiyuki medermycininhibitstnfapromotedinflammatoryreactioninhumansynovialfibroblasts AT itakuramakoto medermycininhibitstnfapromotedinflammatoryreactioninhumansynovialfibroblasts AT inouegen medermycininhibitstnfapromotedinflammatoryreactioninhumansynovialfibroblasts AT muneshigekyoko medermycininhibitstnfapromotedinflammatoryreactioninhumansynovialfibroblasts AT hirosetomoyasu medermycininhibitstnfapromotedinflammatoryreactioninhumansynovialfibroblasts AT iwatsukimasato medermycininhibitstnfapromotedinflammatoryreactioninhumansynovialfibroblasts AT takasomasashi medermycininhibitstnfapromotedinflammatoryreactioninhumansynovialfibroblasts AT miyagimasayuki medermycininhibitstnfapromotedinflammatoryreactioninhumansynovialfibroblasts AT uchidakentaro medermycininhibitstnfapromotedinflammatoryreactioninhumansynovialfibroblasts |